ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
Hosted on MSN1d
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals GroupEarnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback